Mainly Events of Addcare Bio-Tech Co., Ltd.
2014 AACC Annual Meeting Press ProgramADDCARE is going to attend 2014 AACC in Chicago, USA. Welcome to visit our booth 3754 on 27-31 July 2014 in McCormick Place - Chicago, USA.
ADDCARE is going to attend 2014 AACC in Chicago, USA. Welcome to visit our booth 3754 on 27-31 July 2014 in McCormick Place - Chicago, USA.
In only ten years since its foundation, AESKU.DIAGNOSTICS has become a recognized name in the field of autoimmunity by launching over 140 different products. It also offers uninterrupted services in more than 80 countries worldwide.
Chemclin’s new Vitamin D assay provides components for in-vitro quantitative determination of 25-Hydroxy Vitamin D (25-OH Vitamin D) in human serum by a competitive chemiluminescent assay method.
Chemclin’s Anti-TB assay provides components for in-vitro qualitative determination of Antibody to Mycobacterium Tuberculosis (Anti-TB) in human serum or plasma by an indirect chemiluminescent assay method.
Applied and effortless simplicity of Burkert products have always been something to rely on – now we have added pure flexibility to the list of standards you can expect.
Complies with American College of Rheumatology (ACR) ANA Position Statement.
Randox Laboratories has further expanded its market presence in the United States, having been awarded a major supplier agreement with Novation, the leading health care supply chain expertise, analytics and contracting company.
Elevated levels of Lipoprotein(a), (Lp(a)), are considered to be both a causal risk factor and major independent genetic marker of atherosclerotic disorders. What differentiates Lipoprotein(a) testing is that the association between higher Lipoprotein(a) levels and increased CVD risk is continuous and does not depend on raised LDL levels or non-HDL cholesterol, or other CVD risk factors.
As a more sensitive maker of renal dysfunction Randox Cystatin C offers several advantages over traditional creatinine assays.
Randox has developed a versatile range of clinical chemistry analyzers with real cost saving in mind.
NuAire offers a full line of Centrifuges, the Prism™ Mini is a reliable, compact, and economical personal Micro-centrifuge ideal for quick spins that can be used for a wide range of molecular biology protocols. Prism™ Mini works out of the box with a maintenance-free drive system and advanced design providing quiet operation and proper ventilation protecting temperature-sensitive samples.
These couplings are LinkTech's newest polypropylene couplings available now.
NuAire’s Glacier -86°C Ultralow Temperature Freezers provides laboratory professionals a safe, reliable freezer that they can depend on. Each freezer is designed with the most advanced features and benefits available for research, laboratory work, clinical and industrial applications, and has unmatched economical storage, providing the best value found in an ultralow freezer.
NuAire offers both Direct Heat and Water Jacket CO2 Incubators assuring the highest level of performance and dependability for optimum growth conditions.
NuAire’s AireGard ES NU-201 Table Top and NU-301 Console Horizontal Laminar Airflow Hoods provide a HEPA filtered clean work area that is ideal for operations requiring a particle-free, bacteria-free, clean air environment. The Class 5 clean work area offers an excellent work space for small laboratory appliances, microscopes, pipetting, sterile drug preparations, IV admixture preparation, or any application requiring work-in-progress protection from outside potentially harmful contaminants.
Experience Ergonomics™. Work comfortably with NuAire Biosafety Cabinets.
These couplings are LinkTech's smallest connectors yet.
These couplings are LinkTech's first dual set couplings.
Recently, the International Medical Reference Laboratory Proficiency Testing Results (RELA2013) has been published. The projects of MAKER all meet the requirements. Since 2008, MAKER has participated RELA experiments six years in a row, and the projects have been all qualified.
As the first company obtained CNAS medical reference laboratory accreditation in China, Maker provide hundreds of high-quality products to satisfy the different needs from customers.
The blood coagulation system of MAKER, provides integrated solutions and meets various demands of different clinical labs.
IS 1200 Automatic Chemiluminescence Immunoassay System provides systematic solution for lab, integrating instrument, reagent, calibrator, and control.
Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information and services, today announced that its Focus Diagnostics products business has received expedited FDA 510(k) clearance and CLIA moderate complexity categorization for its new Simplexa™ HSV 1 & 2 Direct molecular test on the 3M Integrated Cycler.
hc1.com®, the Healthcare Relationship CloudTM company, and Beckman Coulter Diagnostics, a global leader in developing clinical diagnostic products that help advance and optimize the laboratory, announced a strategic partnership to deliver innovative technology to laboratories that turn large amounts of clinical data into actionable insights that transform how labs manage their business and their contributions to improving healthcare.
The DRG:Hybrid-XL® will be showcased as the centerpiece of DRG International’s display at the 2014 AACC conference in Chicago, IL.
DRG International, a leading international medical diagnostic company, will showcase its DRG Hepcidin 25 (bioactive) ELISA Kit (EIA-5258) at the 2014 AACC in Chicago, IL from July 27-31.
DRG International, a leading international medical diagnostic company, will showcase its DRG Aldosterone ELISA Kit at the 2014 AACC in Chicago, IL from July 27-31.
Diazyme Laboratories today announced that the U.S. Food and Drug Administration (FDA) has granted 510(K) clearance to market its Vitamin D assay for Clinical Chemistry Analyzers.
These couplings are LinkTech's newest products that are set to hit the market very soon.
COLA, the largest private accreditor of medical laboratories serving more than 8,000 across the U.S., successfully concluded its 2014 Leadership Summit in April.
The nation’s healthcare system -- and with it, the laboratory community – is undergoing a period of tremendous change as The Affordable Care Act begins implementation and new healthcare delivery models such as The Patient-Centered Medical Home (PCMH) and Accountable Care Organizations (ACOs) proliferate.
COLA Inc., based in Columbia, MD, an independent, nonprofit laboratory CLIA-accreditation organization, accrediting more than 7,000 clinical diagnostic labs on July, 2013, launched a new education subsidiary, COLA Resources Inc. (CRI®), whose mission is to “Provide educational & consultative services aimed at improving laboratory medicine and patient care.”
As a leading educator in laboratory medicine, COLA Resources Inc.’s (CRI®) goal is to continually update our education platform to reflect and support education regarding changes in regulatory requirements.
Attending the CRI® Symposium for Clinical Laboratories, affords participants the opportunity to participate in discussions centered on EDUCATION FOR LABORATORY EXCELLENCE – making a positive impact for quality patient care. This year’s symposium will be held October 15-18, 2014 at the Buena Vista Palace Hotel & Spa Lake Buena Vista (Orlando), FL. Participants can attend a wide selection of educational sessions, earn up to 20 CME or P.A.C.E® credits, network with other healthcare professionals and visit the exhibit hall featuring the latest laboratory technology, equipment and supplies.
The DRG 25-OH Vitamin D (total) ELISA, an enzyme immunoassay for the measurement of total 25-OH Vitamin D (Vitamin D2 and Vitamin D3) in both serum and plasma, will be a highlight of the 2014 American Association for Clinical Chemistry (AACC) Conference.
DRG International’s Renin (Active) ELISA for testing of active Renin in human EDTA plasma will be on display at the AACC’s 2014 show in Chicago, IL on July 27-31.
As a leading manufacturer of raw material for IVD industry, Fapon Biotech Inc. discovers, develops and provides innovative antigen, antibodies and enzymes that deliver significant benefits to IVD industry.
Now a new study by researchers affiliated with New York University's Center for Drug Use and HIV Research (CDUHR), in the August 2014 edition of Pediatrics identifies how prevalent Hookah use is and which teens are most likely to be using it.
Neuroscientists leading the largest longitudinal adolescent brain imaging study to date have learned that a number of factors – genetics, brain function and about 40 different variables – can help scientists predict which teens will become binge drinkers.
A Johns Hopkins-led research team has found that motivational interviewing, along with standard education and awareness programs, significantly reduced secondhand smoke exposure among children living in those households.
Combining two smoking cessation therapies is more effective than using just one for male and highly nicotine-dependent smokers who weren't initially helped by the nicotine patch, according to researchers at Duke Medicine.
Researchers at the University of California, San Diego School of Medicine have completed the first comprehensive survey of e-cigarettes for sale online and the results, they believe, underscore the complexity in regulating the rapidly growing market for the electronic nicotine delivery devices.
Community opioid overdose prevention programs (OOPPs)—including the use of naloxone for rapid drug reversal—can improve bystander responses to overdose of heroin and related drugs, according to a review in the June Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
A nationwide survey of heroin users indicates that they are attracted to the drug not only for the “high” but because it is less expensive and easier to get than prescription painkillers, and Washington University researchers have found that many suburban drug users have made the switch.
Scientists and physicians at UC San Francisco (UCSF) are leading a $26 million, multi-institutional research program in which they will employ advanced technology to characterize human brain networks and better understand and treat a range of common, debilitating psychiatric disorders, focusing first on anxiety disorders and major depression.
A vast majority of so-called “super-frequent user” patients who seek care in the Emergency Department (ED) have a substance abuse addiction, according to a Henry Ford Hospital study. A patient is considered a super-frequent user who visits the ED at least 10 times a year.
People who inject drugs and are enrolled in a drug treatment program are receptive to education about, and treatment for, hepatitis C virus, according to a study by researchers at several institutions, including the University at Buffalo.
A team led by Maciej Goniewicz of Roswell Park Cancer Institute found that high-voltage electronic cigarettes may expose users to increased levels of toxic chemicals, including formaldehyde and acetaldehyde.
–– A research team from the Friedman Brain Institute of the Icahn School of Medicine at Mount Sinai published evidence showing that subtle changes of inhibitory signaling in the reward pathway can change how animals respond to drugs such as cocaine. This is the first study to demonstrate the critical links between the levels of the trafficking protein, the potassium channels’ effect on neuronal activity and a mouse’s response to cocaine. Results from the study were published in the peer-reviewed journal Neuron earlier this month.
Stimulation of a certain population of neurons within the brain can alter the learning process, according to a team of neuroscientists and neurosurgeons at the University of Pennsylvania. A report in the Journal of Neuroscience describes for the first time that human learning can be modified by stimulation of dopamine-containing neurons in a deep brain structure known as the substantia nigra.